Literature DB >> 25272245

Importance of Toll-like receptor 2 in mitochondrial dysfunction during polymicrobial sepsis.

Yu Gong1, Lin Zou, Yan Feng, Dan Li, Jiayan Cai, Dunjin Chen, Wei Chao.   

Abstract

BACKGROUND: Toll-like receptor 2 (TLR2) contributes to sepsis pathogenesis such as deleterious systemic inflammation, cardiac dysfunction, and high mortality in animal studies. Mitochondrial dysfunction is a key molecular event that is associated with organ injury in sepsis. The role of TLR2 in sepsis-induced mitochondrial dysfunction remains unclear.
METHODS: Intracellular hydrogen peroxide (H2O2), mitochondrial superoxide (O2), mitochondrial membrane potential (ΔΨm), and intracellular adenosine triphosphate (ATP) were measured in peritoneal leukocytes. A mouse model of polymicrobial sepsis was generated by cecum ligation and puncture (CLP). Wild-type and TLR2-deficient (TLR2) mice were subjected to sham or CLP. Mitochondrial functions including reactive oxygen species (ROS), ΔΨm, intracellular ATP, and complex III activity were measured.
RESULTS: TLR2/1 activation by Pam3Cys enhanced intracellular H2O2 and mitochondrial O2 production in leukocytes, but had no effect on mitochondrial ΔΨm and ATP production. The effect was specific for TLR2/1 as TLR3 or TLR9 ligands did not induce ROS production. Polymicrobial sepsis induced mitochondrial dysfunction in leukocytes, as demonstrated by increased H2O2 and mitochondrial O2- production (CLP vs. sham; H2O2: 3,173±498, n=5 vs. 557±38, n=4; O2-: 707±66, n=35 vs. 485±35, n=17, mean fluorescence intensity, mean±SEM), attenuated complex III activity (13±2, n=16 vs. 30±3, n=7, millioptical densities/min), loss of mitochondrial ΔΨm, and depletion of intracellular ATP (33±6, n=11 vs. 296±29, n=4, nmol/mg protein). In comparison, there was significant improvement in mitochondrial function in septic TLR2-/- mice as evidenced by attenuated mitochondrial ROS production, better-maintained mitochondrial ΔΨm, and higher cellular ATP production.
CONCLUSIONS: TLR2 signaling plays a critical role in mediating mitochondrial dysfunction in peritoneal leukocytes during polymicrobial sepsis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25272245      PMCID: PMC4237710          DOI: 10.1097/ALN.0000000000000470

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  64 in total

Review 1.  Laboratory models of sepsis and septic shock.

Authors:  M P Fink; S O Heard
Journal:  J Surg Res       Date:  1990-08       Impact factor: 2.192

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 3.  Reactive oxygen species and mitochondrial diseases.

Authors:  I G Kirkinezos; C T Moraes
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

4.  Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.

Authors:  Frédéric Pène; David Grimaldi; Benjamin Zuber; Bertrand Sauneuf; Christophe Rousseau; Carole El Hachem; Clémence Martin; Nadia Belaïdouni; Viviane Balloy; Jean-Paul Mira; Jean-Daniel Chiche
Journal:  J Infect Dis       Date:  2012-07-10       Impact factor: 5.226

5.  Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis.

Authors:  Jose C Alves-Filho; Andressa Freitas; Fabricio O Souto; Fernando Spiller; Heitor Paula-Neto; Joao S Silva; Ricardo T Gazzinelli; Mauro M Teixeira; Sergio H Ferreira; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

6.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure.

Authors:  David Brealey; Sekhar Karyampudi; Thomas S Jacques; Marco Novelli; Ray Stidwill; Val Taylor; Ryszard T Smolenski; Mervyn Singer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-11-06       Impact factor: 3.619

Review 8.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Authors:  Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

9.  Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1.

Authors:  Hagir B Suliman; Martha S Carraway; Karen E Welty-Wolf; A Richard Whorton; Claude A Piantadosi
Journal:  J Biol Chem       Date:  2003-08-05       Impact factor: 5.157

Review 10.  The role of mitochondrial dysfunction in sepsis-induced multi-organ failure.

Authors:  Mervyn Singer
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

View more
  10 in total

1.  Protective effects of exogenous NaHS against sepsis-induced myocardial mitochondrial injury by enhancing the PGC-1α/NRF2 pathway and mitochondrial biosynthesis in mice.

Authors:  Dongshi Liang; Airong Huang; Yimei Jin; Miaomiao Lin; Xiaojiao Xia; Xiaoli Chen; Airong Huang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

2.  Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors.

Authors:  Julie A Pollock; Naina Sharma; Sirish K Ippagunta; Vanessa Redecke; Hans Häcker; John A Katzenellenbogen
Journal:  ChemMedChem       Date:  2018-09-13       Impact factor: 3.466

3.  Poly (ADP-ribose) synthetase inhibitor has a heart protective effect in a rat model of experimental sepsis.

Authors:  Lianshuang Zhang; Jinpeng Yao; Xifeng Wang; Hongxing Li; Tongshen Liu; Wei Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials.

Authors:  Fengqian Chen; Lin Zou; Brittney Williams; Wei Chao
Journal:  Antioxid Redox Signal       Date:  2021-04-07       Impact factor: 8.401

5.  The role of myeloid differentiation factor 88 on mitochondrial dysfunction of peritoneal leukocytes during polymicrobial sepsis.

Authors:  Yu Gong; Lin Zou; Dunjin Chen; Wei Chao
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

6.  Use of plasma mitochondrial DNA levels for determining disease severity and prognosis in pediatric sepsis: a case control study.

Authors:  Hai Peng Yan; Miao Li; Xiu Lan Lu; Yi Min Zhu; Wen-Xian Ou-Yang; Zheng Hui Xiao; Jun Qiu; Shuang Jie Li
Journal:  BMC Pediatr       Date:  2018-08-09       Impact factor: 2.125

7.  mtROS Induced via TLR-2-SOCE Signaling Plays Proapoptotic and Bactericidal Role in Mycobacterium fortuitum-Infected Head Kidney Macrophages of Clarias gariepinus.

Authors:  Priyanka Dahiya; Md Arafat Hussain; Shibnath Mazumder
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

8.  Circadian Rhythms Influence the Severity of Sepsis in Mice via a TLR2-Dependent, Leukocyte-Intrinsic Mechanism.

Authors:  Erica L Heipertz; Jourdan Harper; Charlie A Lopez; Erol Fikrig; Michael E Hughes; Wendy E Walker
Journal:  J Immunol       Date:  2018-05-14       Impact factor: 5.426

9.  MFHAS1 Is Associated with Sepsis and Stimulates TLR2/NF-κB Signaling Pathway Following Negative Regulation.

Authors:  Jing Zhong; Qi-Qing Shi; Min-Min Zhu; Jian Shen; Hui-Hui Wang; Duan Ma; Chang-Hong Miao
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

Review 10.  Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.

Authors:  Russell B Hawkins; Steven L Raymond; Julie A Stortz; Hiroyuki Horiguchi; Scott C Brakenridge; Anna Gardner; Philip A Efron; Azra Bihorac; Mark Segal; Frederick A Moore; Lyle L Moldawer
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.